Interleukin-23 Antagonist [EPC]

104720 reported adverse events

Drugs of this class: USTEKINUMAB-TTWE USTEKINUMAB USTEKINUMAB-AAUZ GUSELKUMAB MIRIKIZUMAB-MRKZ RISANKIZUMAB-RZAA TILDRAKIZUMAB-ASMN USTEKINUMAB-AEKN USTEKINUMAB-AUUB USTEKINUMAB-HMNY USTEKINUMAB-STBA

These side effects are most commonly reported by patients taking drugs of the Interleukin-23 Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 15055
1 OFF LABEL USE 12962
2 PRODUCT DOSE OMISSION ISSUE 10267
3 FATIGUE 7009
4 PSORIASIS 6639
5 PAIN 6347
6 CROHN^S DISEASE 6090
7 ARTHRALGIA 5952
8 RASH 5751
9 PRODUCT USE ISSUE 5476
See all common reactions for Interleukin-23 Antagonist [EPC]

Drugs of the Interleukin-23 Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 414 0.6198
1 SWOLLEN JOINT COUNT INCREASED 1922 0.6021
2 RHEUMATIC FEVER 2543 0.5699
3 LUPUS VULGARIS 682 0.5413
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 1066 0.5322
5 C-REACTIVE PROTEIN 492 0.5307
6 RHEUMATOID FACTOR POSITIVE 2982 0.5157
7 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3625 0.5054
8 FACET JOINT SYNDROME 1431 0.4391
9 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 883 0.4257
See all enriched reactions for Interleukin-23 Antagonist [EPC]